Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Jacobs

Showing results (131-140 of 264) with videos related to

Pageof 27
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1996
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenemS K Spangler, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1996
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococciL M Ednie, M A Visalli, M R Jacobs, et al.
Journal of Clinical Microbiology|April 4, 2000
Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologiesT A Davies, L M Kelly, M R Jacobs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 2000
Activity of trovafloxacin, alone and in combination with other agents, against Enterobacteriaceae by time-kill analysisC L Clark, L M Kelly, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsG A Pankuch, M R Jacobs, S F Rittenhouse, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniaeT A Davies, B E Dewasse, M R Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2003
In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compoundsD B Hoellman, L M Kelly, M R Jacobs, et al.
Journal of Biomedical Materials Research|April 1, 1995
Adhesion of Staphylococcus epidermidis to biomedical polymers: contributions of surface thermodynamics and hemodynamic shear conditionsI W Wang, J M Anderson, M R Jacobs, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 24, 2001
Centralized, pharmacist-managed anticoagulation service for a university-based health systemF A Farnsworth, K Y Kim, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococciD B Hoellman, G A Pankuch, M R Jacobs, et al.
Pageof 27

Showing results (131-140 of 264) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|March 1, 1996
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenemS K Spangler, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1996
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococciL M Ednie, M A Visalli, M R Jacobs, et al.
Journal of Clinical Microbiology|April 4, 2000
Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologiesT A Davies, L M Kelly, M R Jacobs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 2000
Activity of trovafloxacin, alone and in combination with other agents, against Enterobacteriaceae by time-kill analysisC L Clark, L M Kelly, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methodsG A Pankuch, M R Jacobs, S F Rittenhouse, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniaeT A Davies, B E Dewasse, M R Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 10, 2003
In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compoundsD B Hoellman, L M Kelly, M R Jacobs, et al.
Journal of Biomedical Materials Research|April 1, 1995
Adhesion of Staphylococcus epidermidis to biomedical polymers: contributions of surface thermodynamics and hemodynamic shear conditionsI W Wang, J M Anderson, M R Jacobs, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 24, 2001
Centralized, pharmacist-managed anticoagulation service for a university-based health systemF A Farnsworth, K Y Kim, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococciD B Hoellman, G A Pankuch, M R Jacobs, et al.
Pageof 27